NCT03370289View on ClinicalTrials.gov

A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

Pandemic Influenza Prevention

Interventions

BIOLOGICAL

BLB-750 Vaccine (Qinghai RG strain)

BLB-750 Injection

Trial Locations (1)

Unknown

Sekino Rinsho Yakuri Clinic, Toshima-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY